Case Reports

CD20 re-emergence in a patient with diffuse large b-cell lymphoma who experienced a CD20-negative relapse after glofitamab treatment

Weill Cornell Medicine, New York, NY
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
Haematologica Early view May 14, 2026 https://doi.org/10.3324/haematol.2025.300182